In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IS Pharma PLC

Division of Huadong Medicine Co. Ltd.
www.ispharma.plc.uk

Latest From IS Pharma PLC

Parkinson's Needs FDA Flexibility, NIH Funding Certainty

With Parkinson's affecting about six million people worldwide – with some estimates putting it as high as 10 million – and the condition becoming increasingly burdensome on health systems around the globe, "we don't have to do a lot of convincing" the disease is worthwhile to invest in and pursue for new treatments, said Todd Sherer, CEO of the Michael J. Fox Foundation (MJFF).

Neurology Israel

Editorial: Spoilt? Pharma? Surely Some Mistake

Some people reckon that what others say of us is none of our business. It's a useful maxim for retaining sanity in the Twitter and Google age, but perhaps there are times when a bit of constructive criticism is good for the soul. We all know that the public perception of the pharma industry isn't great, but the opinions of an Ivy League economics professor laid out in a recent JAMA Forum commentary may sting. Paraphrasing, it seems Professor Uwe Reinhardt thinks you're a bit spoilt: fragile little birds shielded by government from the harsh realities of the free market, and enjoying monopoly positions. He's got a point.

Infectious Diseases Cancer

STOCKWATCH: Waiting for the biotech bubble to burst

Everybody's wondering, when will the biotech bubble burst? Whilst there have been IPOs cancelled citing "market conditions", news of many more primary and secondary offerings continues to appear in our in boxes. Logic dictates that the bubble will burst eventually and indeed in the last year we've already had two warning pops caused by drug pricing concerns, but the NASDAQ Biotech Index has continued its relentless climb. Even so, fresh evidence is appearing that the bubble is about to die, starting with this latest earnings season

Cardiovascular

Pharma a long way from MINT condition

As late as last year, some pundits were predicting that the emerging economies of the BRIC countries – Brazil, Russia, India and China – would be the salvation of the multinational pharmaceutical companies that were facing growing generic competition and lacklustre pipelines in their domestic markets.

Turkey
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Maelor PLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Huadong Medicine Co. Ltd.
  • Senior Management
  • Tim Wright, CEO
    Matthew Hall, CFO
    Nairn McMaster, Commercial Dir.
  • Contact Info
  • IS Pharma PLC
    Phone: 1244 625150
    Office Village, Chester Business Park
    Chester, CH4 9QZ
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register